Best Anna Rehbein Podcasts (2024)

1
Blood Biomarkers to Detect Alzheimer Disease - Part 1 1:41

8h ago1:41

1:41

In part one of this two-part series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss the top-line findings from the study exploring the diagnostic performance of blood biomarkers for Alzheimer disease in clinical cohorts. Show reference: https://jamanetwork.com/journals/jama/fullarticle/2821669By American Academy of Neurology

1
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 1 1:12

3h ago1:12

1:12

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Calium discuss the risk of developing dementia among patients with MCI at three or five-year time points. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209499By American Academy of Neurology

1
New Treatment Option for Parkinson Disease 2:33

6h ago2:33

2:33

Dr. Jeff Ratliff talks about the FDA approval of Crexont for the treatment of Parkinson disease. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2808496By American Academy of Neurology

1
Chronic Adaptive Deep Brain Stimulation Versus Conventional Stimulation in Parkinson Disease 3:07

2h ago3:07

3:07

Dr. Jeff Ratliff discusses an exciting study in the world of deep brain stimulation for Parkinson disease. Show reference: https://www.nature.com/articles/s41591-024-03196-zBy American Academy of Neurology

1
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse 2:03

8h ago2:03

2:03

Dr. Tesha Monteith talks about the efficacy of atogepant for the preventive treatment of chronic migraine in participants with and without acute medication overuse. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209584By American Academy of Neurology

1
Neuropsychological Profiles of Deployment-Related mTBI 3:05

1d ago3:05

3:05

Dr. Stacey Clardy and Dr. Nicola de Souza discuss how to improve care in the clinic for these veterans and military service members. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209417By American Academy of Neurology

1
Long-Term Dementia Risk in Parkinson Disease - Part 1 2:37

3h ago2:37

2:37

In the first installment of this two-part series, Dr. Jeff Ratliff and Dr. Daniel Weintraub discuss the risks associated with the development of dementia in patients diagnosed with Parkinson disease. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209699By American Academy of Neurology

1
Interpreting DAT Imaging Results in the Clinical Context - Part 2 2:01

9d ago2:01

2:01

In part two of this two-part series, Dr. Jeff Ratliff and Dr. Eduardo De Pablo-Fernández discuss why clinicians should be cautious when relying too much on dopaminergic imaging. Show reference: https://doi.org/10.1212/WNL.0000000000209453By American Academy of Neurology

1
Understanding Long COVID - Part 2 1:55

7d ago1:55

1:55

In part two of this two-part series, Dr. Tesha Monteith discusses the key features of long COVID. Show reference: https://doi.org/10.17226/27768By American Academy of Neurology

1
Understanding Long COVID - Part 1 1:30

7h ago1:30

1:30

In part one of this two-part series, Dr. Tesha Monteith discusses the 2024 National Academies of Sciences, Engineering, and Medicine formal definition of long COVID. Show reference: https://doi.org/10.17226/27768By American Academy of Neurology

1
Interpreting DAT Imaging Results in the Clinical Context 1:37

11d ago1:37

1:37

Dr. Jeff Ratliff and Dr. Eduardo De Pablo-Fernández discuss the strengths of dopamine transporter imaging or DAT imaging in diagnosing patients with Parkinsonian disorders. Show references: https://doi.org/10.1212/WNL.0000000000209453By American Academy of Neurology

1
New Data and New Controversies on Cardiac Monitoring and Anticoagulation - Part 1 2:33

8d ago2:33

2:33

Dr. Dan Ackerman and Dr. Luciano A. Sposato discuss the topic of embolic stroke of undetermined sources and the controversies surrounding cardiac monitoring and anticoagulation. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209535By American Academy of Neurology

1
AHS Position Statement 2:11

13d ago2:11

2:11

Dr. Tesha Monteith provides an overview of the updated position statement on migraine prevention by the American Headache Society.By American Academy of Neurology

1
Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core - Part 2 3:19

3h ago3:19

3:19

In part two of this two-part series, Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the differences in treatment between American Stroke Centers and those in France. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398By American Academy of Neurology

1
Transient Smartphone Blindness 1:55

1d ago1:55

1:55

Dr. Meagan Seay discusses a relatively recently described but very interesting phenomenon called transient smartphone blindness. This is a phenomenon causing acute, painless, transient, monocular vision loss associated with smartphone use while lying down in the dark. Show reference: Transient Smartphone Blindness - EyeWiki…

1
Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core 2:17

4d ago2:17

2:17

Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the efficacy and safety of both thrombolytics in patients with large ischemic core. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398By American Academy of Neurology

1
The Ethical Landscape of Prodromal Parkinson Disease 2:13

23d ago2:13

2:13

Dr. Jason Crowell and Dr. Colin Hoy discuss the concept of prodromal Parkinson disease and the ethical considerations surrounding its diagnosis. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209522By American Academy of Neurology

1
Movement Disorders Emergencies - Part 3 2:40

20d ago2:40

2:40

In the last episode of this three-part series, Dr. Jeff Ratliff discusses how to approach patients presenting with emergent rigidity and difficulty moving.By American Academy of Neurology

1
Movement Disorders Emergencies - Part 2 3:48

7d ago3:48

3:48

In the second episode of this three-part series, Dr. Jeff Ratliff provides a rapid overview of hyperkinetic disorders that require urgent attention.By American Academy of Neurology

1
Movement Disorders Emergencies - Part 1 3:00

20d ago3:00

3:00

In the first episode of this three-part series, Dr. Jeff Ratliff discusses a few key points to help recognize and initiate treatment for patients with movement disorder emergencies, focusing on the initial approach to these disorders. It is important to consider medications, labs, and imaging as part of the evaluation process.…

1
Association of Prenatal Exposure to Antiseizure Medications 2:24

29d ago2:24

2:24

Dr. Halley Alexander and Dr. Kimford Meador discuss perinatal exposure to anti-seizure medications and its effects on creativity and executive function in children. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209448By American Academy of Neurology

1
Tapping the Brakes on New Parkinson Disease Biological Staging 2:43

1M ago2:43

2:43

Dr. Matthew Barrett and Dr. Michael S. Okun discuss the caution and deliberation needed in understanding Parkinson disease biomarkers. Show reference: https://jamanetwork.com/journals/jamaneurology/article-abstract/2820441By American Academy of Neurology

1
Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 2 3:16

1M ago3:16

3:16

In the final episode of this two-part series, Dr. Joe Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Ravulizumab + zilucoplan. Show references: https://doi.org/10.1016/…

1
Large Language Models for Quality and Efficiency of Neurologic Care - Part 2 2:40

1M ago2:40

2:40

In the final part of this two-part series, Dr. Andy Southerland and Dr. Lidia Moura discuss strategies on how clinicians can mitigate bias when using large language models. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209497By American Academy of Neurology

1
Transcobalamin Receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency - Part 2 2:15

1M ago2:15

2:15

Dr. Justin Abbatemarco, Dr. Michael R. Wilson, and Dr. John Pluvinage discuss their discovery of anti-CD320 antibodies in patients with neurologic manifestations of B12 deficiency and discuss the potential implications for diagnosis and treatment. Show reference: https://www.science.org/doi/10.1126/scitranslmed.adl3758…

Podcasts Worth a Listen

Anna Rehbein Podcasts

Podcasts Worth a Listen

1
Neurology Minute

American Academy of Neurology

1
Blood Biomarkers to Detect Alzheimer Disease - Part 1 1:41

1
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 1 1:12

1
New Treatment Option for Parkinson Disease 2:33

1
Chronic Adaptive Deep Brain Stimulation Versus Conventional Stimulation in Parkinson Disease 3:07

1
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse 2:03

1
Neuropsychological Profiles of Deployment-Related mTBI 3:05

1
Long-Term Dementia Risk in Parkinson Disease - Part 1 2:37

1
Interpreting DAT Imaging Results in the Clinical Context - Part 2 2:01

1
Understanding Long COVID - Part 2 1:55

1
Understanding Long COVID - Part 1 1:30

1
Interpreting DAT Imaging Results in the Clinical Context 1:37

1
New Data and New Controversies on Cardiac Monitoring and Anticoagulation - Part 1 2:33

1
AHS Position Statement 2:11

1
Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core - Part 2 3:19

1
Transient Smartphone Blindness 1:55

1
Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core 2:17

1
The Ethical Landscape of Prodromal Parkinson Disease 2:13

1
Movement Disorders Emergencies - Part 3 2:40

1
Movement Disorders Emergencies - Part 2 3:48

1
Movement Disorders Emergencies - Part 1 3:00

1
Association of Prenatal Exposure to Antiseizure Medications 2:24

1
Tapping the Brakes on New Parkinson Disease Biological Staging 2:43

1
Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 2 3:16

1
Large Language Models for Quality and Efficiency of Neurologic Care - Part 2 2:40

1
Transcobalamin Receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency - Part 2 2:15

Quick Reference Guide